FOUNDATION FOR SARCOIDOSIS RESEARCH (EIN 364378232) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

MARY COBB

Phone

3123410500

Tax Period

2024-01-01 to 2024-12-31

FOUNDATION FOR SARCOIDOSIS RESEARCH, founded in 2000, is a mid-sized nonprofit in the Philanthropy & Grantmaking sector that reported $13.6M in total revenue in fiscal year 2024. Revenue surged 428% from the prior year, signaling strong growth momentum. The organization ran a surplus of $10.2M, a strong 75% operating margin.

Mission

THE FOUNDATION FOR SARCOIDOSIS RESEARCH (FSR) IS THE LEADING INTERNATIONAL ORGANIZATION DEDICATED TO FINDING A CURE FOR SARCOIDOSIS AND IMPROVING CARE FOR SARCOIDOSIS PATIENTS THROUGH RESEARCH, EDUCATION, AND SUPPORT. SINCE ITS ESTABLISHMENT IN 2000, FSR HAS FOSTERED OVER $7.5 MILLION IN SARCOIDOSIS SPECIFIC RESEARCH EFFORTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $13,025,070

Program Service Revenue $192,325

Investment Income $364,032

Other Revenue $4,438

TOTAL REVENUE $13,585,865

Expense Breakdown

Grants Paid $952,335

Salaries & Benefits $1,334,219

Fundraising Expenses $211,631

Program Expenses $2,567,054

Other Expenses $1,081,462

TOTAL EXPENSES $3,368,016

Year-over-Year Comparison

	2024	2023	Change
Revenue	$13,585,865	$2,574,104	+4.3%
Expenses	$3,368,016	$2,402,436	+0.4%
Net Income	$10,217,849	$171,668	+58.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

125

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$489,532

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARY COBB	PRESIDENT	10.00	Officer Director	$0	$0	$0
HEIDI W JUNK	VICE PRESIDENT (THRU DEC-2024)	5.00	Officer Director	$0	$0	$0
MICHAEL KAPLAN	TREASURER (THRU DEC-2024)	5.00	Officer Director	$0	$0	$0
JOEL ROSEN	SECRETARY	5.00	Officer Director	$0	$0	$0
YVETTE C COZIER	DIRECTOR	1.00	Director	$0	$0	$0
EMERSON RANDY HALL JR	DIRECTOR	1.00	Director	$0	$0	$0
CALVIN HARRIS	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL KLINGHER	DIRECTOR	1.00	Director	$0	$0	$0
JEFFREY RAICH	DIRECTOR	1.00	Director	$0	$0	$0
LOUISE M PERKINS	DIRECTOR	1.00	Director	$0	$0	$0
CRAIG LIPSET	DIRECTOR	1.00	Director	$0	$0	$0
LESLIE SERCHUCK	DIRECTOR	1.00	Director	$0	$0	$0
REV MICHAEL A WALROND JR	DIRECTOR (THRU NOV-24)	1.00	Director	$0	$0	$0
MARY MCGOWAN	PRESIDENT & CEO	40.00	Officer	$256,000	$16,376	$272,376
TRICHA SHIVAS	CHIEF OF STAFF AND STRATEGY	40.00	Officer	$200,600	$16,556	$217,156

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$13,585,865	$3,368,016	$17,183,158	$10,217,849
2023	$2,574,104	$2,402,436	$5,742,895	$171,668
2022	$1,673,599	$2,027,945	$4,929,854	$-354,346
2021	$2,385,283	$1,728,967	$6,004,041	$656,316
2020	$1,785,472	$1,389,197	$5,212,814	$396,275
2019	$2,172,152	$2,666,891	$4,488,567	$-494,739
2018	$4,058,860	$2,454,428	$4,456,932	$1,604,432

FOUNDATION FOR SARCOIDOSIS RESEARCH